AN ENZYME LINKED IMMUNOSORPTION ASSAY FOR TISSUE FACTOR PATHWAY INHIBITOR
- 1 September 1997
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 87 (5) , 447-459
- https://doi.org/10.1016/s0049-3848(97)00161-8
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Increased Tissue Factor Pathway Inhibitor Activity in IDDM Patients With NephropathyDiabetes Care, 1996
- Effect of Cholesterol Lowering on Intravascular Pools of TFPI and Its Anticoagulant Potential in Type II HyperlipoproteinemiaArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Functional and immunologic methods for the measurement of human tissue factor pathway inhibitorBlood Coagulation & Fibrinolysis, 1995
- Tissue factor pathway inhibitor activity in patients with IDDMDiabetes, 1995
- Measurement of tissue factor pathway inhibitor in normal and post-heparin plasmaBlood Coagulation & Fibrinolysis, 1994
- Tissue-factor pathway inhibitor and lipoproteins. Evidence for association with and regulation by LDL in human plasma.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- Evidence that the C-terminus of tissue factor pathway inhibitor (TFPI) is essential for its in vitro and in vivo interaction with lipoproteinsBlood Coagulation & Fibrinolysis, 1993
- Synergism between full length TFPI and heparinBlood Coagulation & Fibrinolysis, 1992
- Chromogenic substrate assay of extrinsic pathway inhibitor (EPI)Blood Coagulation & Fibrinolysis, 1991
- Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitorNature, 1989